Gene · 10979
Papers1,280
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,280
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DepPrior: integrating CRISPR dependency predictability with multi-omics reproducibility to prioritize candidate LUAD therapeutic targets. | Front Pharmacol | 2026 | 42761694 | PubTator, text mining | PubMed |
| Targeting chitinase-3-like protein-1 in pancolitis by a drug-repurposing approach. | Biochem Pharmacol | 2026 | 42508656 | PubTator, text mining | PubMed |
| ILK binding to β1 integrin is indirect and mediated by kindlin-2. | Proc Natl Acad Sci U S A | 2026 | 42372136 | PubTator, text mining | PubMed |
| Exploring the Toxicological Impact and Mechanisms of DEHP Exposure on Prostate Cancer Through Network Toxicology and Machine Learning Algorithms. | Curr Med Chem | 2026 | 42304923 | PubTator, text mining | PubMed |
| DHT-Induced lncRNA AC092718.4 Promotes Prostate Cancer Cell Proliferation via ceRNA Mechanism. | Genes (Basel) | 2026 | 42194995 | PubTator, text mining | PubMed |
| IFT88/Kindlin-2 Signaling Prevents Mechanical Overloading-Induced PANoptosis of Nucleus Pulposus Cells by Activating FOXP1 SUMOylation. | Int J Biol Sci | 2026 | 42157928 | PubTator, text mining | PubMed |
| The dual role of kindlin-2 in mechanotransduction: A bridge for sensing and a hub for signaling. | Cell Signal | 2026 | 42066827 | PubTator, text mining | PubMed |
| Biophysical membrane responses of hypoxic prostate cancer cells depend on kindlin-2. | Biophys J | 2026 | 42035259 | PubTator, text mining | PubMed |
| Brain Proteomic Responses to Glucocorticoids and Their Relationship With Transcriptome: A Systematic Meta-Analysis. | FASEB J | 2026 | 41996197 | PubTator, text mining | PubMed |
| Kindlins in the cardiovascular system: from development to pathogenesis. | Front Cardiovasc Med | 2026 | 41993866 | PubTator, text mining | PubMed |
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| Functional genomic screens uncover FERMT2 as a critical regulator of YAP/TAZ-driven tumorigenicity. | Cell Death Differ | 2026 | 41792242 | PubTator, text mining | PubMed |
| Binding Mode of Dimeric Kindlin-2 to F-Actin: An Integrated Computational and Experimental Study. | J Phys Chem B | 2026 | 41779665 | PubTator, text mining | PubMed |
| Role and underlying mechanisms of miR‑200 family in breast cancer (Review). | Int J Oncol | 2026 | 41716019 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages in cancer development and their significance as prognostic markers. | Clin Exp Med | 2026 | 41697492 | PubTator, text mining | PubMed |
| Correction: Smurf1 inhibits integrin activation by controlling Kindlin-2 ubiquitination and degradation. | J Cell Biol | 2026 | 41686126 | PubTator, text mining | PubMed |
| Involvement of Non-Muscle Myosin Light Chain Kinase Nitration in Molecular Regulation of Inflammation-Induced Endothelial Cell Barrier Dysfunction. | Cells | 2026 | 41677625 | PubTator, text mining | PubMed |
| Optimum Serum Concentration Enhances Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells and Promotes Intracellular Delivery of Proapoptotic Domain via Cell-Penetrating Peptides. | Mol Pharm | 2026 | 41539681 | PubTator, text mining | PubMed |
| Gray matter microstructure from in vivo diffusion magnetic resonance imaging reflects post mortem neuropathology severity and clinical progression of Alzheimer's disease. | Alzheimers Dement | 2026 | 41532780 | PubTator, text mining | PubMed |
| Force Transmission by Minimal Focal Adhesion Complexes Induces Synthetic Cell Deformation. | ACS Synth Biol | 2026 | 41407554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10979/papers